The tyrosine kinase inhibitor dasatinib (SPRYCEL) inhibits chondrocyte activity and proliferation

Vandyke, K.Fitter, S.Zannettino, A.2012-03-202012-03-202011Blood Cancer Journal, 2011; 1(2):E2-E22044-53852044-5385http://hdl.handle.net/2440/69939Letter to the Editoren© 2011 Macmillan Publishers Limited. All rights reservedThe tyrosine kinase inhibitor dasatinib (SPRYCEL) inhibits chondrocyte activity and proliferationJournal article002011590110.1038/bcj.2011.10002988097000012-s2.0-8486406959226215Vandyke, K. [0000-0002-1033-849X]Fitter, S. [0000-0003-1663-6807]Zannettino, A. [0000-0002-6646-6167]